Lobna Harguem

1PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jun 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.

Jean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier

Pageof 1

Frequent Collaborators

1 joint publications

Jean-Frédéric Blanc

1 joint publications

Mohamed Bouattour

1 joint publications

Emmanuel Deshayes

1 joint publications

Sophie Guillemard

1 joint publications

Yann Touchefeu

1 joint publications

Fabienne Portales

1 joint publications

Rosine Guimbaud

1 joint publications

Marc Ychou

1 joint publications

Thibault Mazard

1 joint publications

Eric Assenat

Frequent Collaborators

1 joint publications

Jean-Frédéric Blanc

1 joint publications

Mohamed Bouattour

1 joint publications

Emmanuel Deshayes

1 joint publications

Sophie Guillemard

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

613
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

613
See more related videos